Show simple item record

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma

dc.contributor.authorMohamed, Abdalla
dc.contributor.authorSun, Congshan
dc.contributor.authorDe Mello, Vanessa
dc.contributor.authorSelfe, Joanna
dc.contributor.authorMissiaglia, Edoardo
dc.contributor.authorShipley, Janet
dc.contributor.authorMurray, Graeme I.
dc.contributor.authorZammit, Pete S.
dc.contributor.authorWackerhage, Henning
dc.date.accessioned2016-09-23T15:00:04Z
dc.date.available2016-09-23T15:00:04Z
dc.date.issued2016-09
dc.identifier.citationMohamed , A , Sun , C , De Mello , V , Selfe , J , Missiaglia , E , Shipley , J , Murray , G I , Zammit , P S & Wackerhage , H 2016 , ' The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma ' , The Journal of pathology , vol. 240 , no. 1 , pp. 3-14 . https://doi.org/10.1002/path.4745en
dc.identifier.issn0022-3417
dc.identifier.otherPURE: 65963588
dc.identifier.otherPURE UUID: 2d033597-fb85-41a8-9edb-aadd5e132f8e
dc.identifier.otherScopus: 84983287800
dc.identifier.otherORCID: /0000-0003-3981-2420/work/76973508
dc.identifier.urihttp://hdl.handle.net/2164/7510
dc.descriptionAcknowledgements This study was funded by Sarcoma UK, Friends of Anchor and the Medical Research Council grant number 99477 awarded to HW and PSZ. This work was also supported, in part, by NHS funding to the NIHR Biomedical Research Centre at the Royal Marsden Hospital and the Institute of Cancer Research, and the Chris Lucas Trust, UK. We also thank the CCLG (Children's cancer and leukaemia group) Tissue Bank for access to samples, and contributing CCLG centres, including members of the ECMC paediatric network. The CCLG Tissue Bank is funded by Cancer Research UK and CCLG. The Zammit lab is also currently supported by Muscular Dystrophy UK (RA3-3052), Association Française Contre les Myopathies (17865, 20082, 19105 and 16050) and the FSH (Fascioscapulohumeral muscular dystrophy) Society (Shack Family and Friends research grant (FSHS-82013-06)). In addition, we would like to thank Prof Kun-Liang Guan and Prof Malcolm Logan for kindly providing constructs.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofThe Journal of pathologyen
dc.rights© 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjecthippo pathwayen
dc.subjectTAZen
dc.subjectWWTR1en
dc.subjectembryonal rhabdomyosarcomaen
dc.subjectmyoblastsen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subject99477en
dc.subject.lccRen
dc.titleThe Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcomaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.University of Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.East Bioen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/path.4745
dc.identifier.vol240en
dc.identifier.iss1en


Files in this item

Thumbnail
Name:
Mohamed_et_al_2016_The_Journal ...
Size:
5.639Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record